Latest Radiopharmacology Stories

SAN DIEGO, March 22 /PRNewswire/ -- Naviscan announced today that Alliance Imaging, a division of Alliance Healthcare Services, will be offering mobile Positron Emission Mammography (PEM) imaging services in the state of Florida. Alliance Imaging will be providing turnkey service which includes transporting the PEM scanner from site to site, a technologist to perform the scan and the necessary radiopharmaceutical, 18F-FDG. When fully implemented, it is anticipated that the service will...

BEDFORD, Mass., March 11 /PRNewswire/ -- VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new VivoTag® 680 XL fluorescent dye for labeling biomolecules in a broad range of in vitro and in vivo imaging applications. VisEn's new near-infrared label, VivoTag® 680 XL, adds an additional imaging label to its current portfolio of VivoTag fluorescent dyes which are used to label specific biomolecules...

MOUNTAIN VIEW, Calif., March 11 /PRNewswire/ -- Based on its recent analysis of the cardiac molecular imaging systems market, Frost & Sullivan recognizes Positron Corporation with the 2010 North American Award for New Product Innovation, for its pioneering cardiac positron emission tomography (PET) scanner, Attrius(TM). The Attrius(TM) was developed and optimized for molecular imaging of the heart, making it the ideal solution for cardiologists and hospitals looking to add high...

Maximizing quality in clinical trials is emphasized at this year's gathering of experts from molecular imaging centers, biomarker manufacturers, regulatory agencies and the pharmaceutical industryA community workshop sponsored by SNM's Clinical Trials Network (CTN) officially kicked off on Feb. 1, in Albuquerque, N.M., and presented participants with a series of educational sessions on the use of molecular imaging in clinical trials for investigational therapeutic drugs. Highly qualified...

NEW YORK, Dec. 8 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Radiopharmaceuticals - A US and European Market Analysis http://www.reportlinker.com/p0164273/Radiopharmaceuticals---A-US-and-European-Market-Analysis.html The market for radiopharmaceuticals continues to gain momentum with heightened interest in therapeutic efficiency, acceptance and utilization of nuclear medicine equipment, as well as development of newer...

NEW YORK, Nov. 20 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Imaging Agents - A Worldwide Market Review http://www.reportlinker.com/p0164325/Imaging-Agents---A-Worldwide-Market-Review.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire Development of contrast agents revolutionized the visualization of organs within the human body. With their inherent ability to bring discrete organs and tissues to...

BEDFORD, Mass., Nov. 19 /PRNewswire/ -- VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new OsteoSense® 800 imaging agent for targeting areas of bone turnover and microcalcification in vivo. The new 800 nm OsteoSense agent complements VisEn's OsteoSense 680 and 750 products, and is expected to further expand the utilization of this agent family in enabling in vivo detection, measurement and...

NEW YORK, Sept. 10 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. US and European Radiopharmaceuticals Market http://www.reportlinker.com/p0109914/US-and-European-Radiopharmaceuticals-Market.html This report analyzes the US and the European markets for Radiopharmaceuticals in Millions of US$. The major product segments analyzed are Diagnostic Radiopharmaceuticals, and Therapeutic Radiopharmaceuticals. Annual forecasts are...

NEW YORK, Sept. 3 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Biologic Imaging Reagents: Technologies and Global Markets http://www.reportlinker.com/p099465/Biologic-Imaging-Reagents-Technologies-and-Global-Markets.html INTRODUCTION STUDY GOALS AND OBJECTIVES BCC's goal for this study is to determine the global market and future demand growth for biologic imaging reagents over a five-year period from 2008 to 2013. Our...

BEDFORD, Mass., Sept. 2 /PRNewswire/ -- VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new Annexin-Vivo 750 imaging agent for measuring and monitoring apoptosis and cell death in vivo. The new Annexin-Vivo 750 agent is based on the well established Annexin labeling standard in in vitro research. It is expected to significantly expand research areas and enhance drug development by enabling real time...